IndiaTickerAnalysts/Institutional Investor Meet/Con. Call Updates - Concord Biotech LimitedNSE · conference call · pdf
Source filing Company dossier
Concord Biotech
NSE:CONCORDBIO · ISIN INE338H01029
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Concord Biotech
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Concord Biotech Ltd - 543960 - Board Meeting Intimation for Meeting To Be Held On Friday, July 31, 2026BSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Concord Biotech LimitedNSE · exchange filing · pdf
Source filing Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Shareholders meeting - Concord Biotech LimitedNSE · exchange filing · pdf
Source filing Record Date - Concord Biotech LimitedNSE · exchange filing · pdf
Source filing Concord Biotech Ltd - 543960 - Notice Of 41St Annual General Meeting Of The Company For The Financial Year 2025-26BSE · exchange filing · pdf
Source filing Concord Biotech Ltd - 543960 - Business Responsibility and Sustainability Reporting (BRSR)BSE · exchange filing · pdf
Source filing Concord Biotech Ltd - 543960 - Intimation Of Record Date And Book Closure DateBSE · exchange filing · pdf
Source filing Concord Biotech Ltd - 543960 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Archived filing Copy of Newspaper Publication - Concord Biotech LimitedNSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Concord Biotech LimitedNSE · exchange filing · pdf
Source filing Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Concord Biotech Ltd - 543960 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Trading Window - Concord Biotech LimitedNSE · exchange filing · pdf
Source filing Concord Biotech Ltd - 543960 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Updates - Concord Biotech LimitedNSE · exchange filing · pdf
Source filing Concord Biotech Ltd - 543960 - Completion Of Inspection By The Pharmacy And Poisons Board (PPB) From Kenya And The National Drug Authority (NDA) From Uganda At Unit-II Formulation FacilityBSE · exchange filing · pdf
Source filing Acquisition - Concord Biotech LimitedNSE · exchange filing · pdf
Source filing Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-AcquisitionBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Concord Biotech LimitedNSE · conference call · pdf
Source filing Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Concord Biotech LimitedNSE · conference call · pdf
Source filing Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Updates - Concord Biotech LimitedNSE · exchange filing · pdf
Source filing Concord Biotech Ltd - 543960 - Completion Of ANVISA Inspection Conducted By The Brazilian Health Regulatory Agency At The Limbasi API Manufacturing FacilityBSE · exchange filing · pdf
Source filing General Updates - Concord Biotech LimitedNSE · exchange filing · pdf
Source filing Concord Biotech Ltd - 543960 - Concord Biotech Secures Abbreviated New Drug Application (ANDA) Approval For Tofacitinib Tablets, 5 Mg And 10 MgBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Concord Biotech LimitedNSE · conference call · pdf
Source filing Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Concord Biotech Ltd - 543960 - Concord Biotech Secures Abbreviated New Drug Application (ANDA) Approval For Mycophenolate Mofetil For Oral Suspension USP, 200 Mg/MlBSE · exchange filing · pdf
Source filing Updates - Concord Biotech LimitedNSE · exchange filing · pdf
Source filing Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · exchange filing · pdf
Source filing Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · other
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Concord Biotech LimitedNSE · conference call · pdf
Source filing Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Investor Presentation - Concord Biotech LimitedNSE · investor presentation · pdf
Source filing Copy of Newspaper Publication - Concord Biotech LimitedNSE · exchange filing · pdf
Source filing